15-01-2013

GATC Biotech has started research on early detection of breast and ovarian cancer with the goal of developing a test to identify tumor markers present in blood and link these markers to the presence of cancer. As a partner of the research project EpiFemCare, GATC Biotech will manage sample ...

more

GATC Biotech customers can expect highest quality standards for Next Generation Sequencing projects from official accreditation

05-12-2012

Being the first in Europe, the Next Generation Sequencing Laboratories of the Constance Genome and Diagnostics Centre has been accredited according to ISO 17025 from the national accreditation body for the Federal Republic of Germany (DAkks). The independent governmental institution has ...

more

Detailed information about the transcriptome help to understand the disease mechanism of a fungal pathogen

16-11-2012

In collaboration with the Max Planck Institute (MPI) for Plant Breeding Research in Cologne GATC Biotech AG has decoded the genome of the fungal pathogen Colletotrichum graminicola. The recently published results show that gene expression plays a decisive role in plant disease. With this ...

more

GATC Biotech joins a new EU research network for young researchers

08-11-2012

Seven European research institutions and GATC Biotech have formed a consortium providing cutting-edge training in the scientific study of the human past. The BEAN (Bridging the European and Anatolian Neolithic) Initial Training Network has been awarded four years of funding from the European ...

more

30 new jobs are planned in 2012

16-11-2011

GATC Biotech continues to grow in 2012. The company will expand the laboratories at its headquarters in Constance and plans to establish a new site in Cologne, Germany.The premises in Constance will become the new European Genome and Diagnostics Center with GATC Biotech’s fleet of Next and ...

more

Project is funded with 500,000 Euros from the BMBF

16-05-2011

On the basis of next generation sequencing technologies GATC Biotech and LifeCodexx will develop a human genetic diagnostic test that will allow the detection of cell-free fetal DNA as an important early marker for Preeclampsia. The test would allow a reliable risk assessment before symptoms ...

more

Facilities will be situated in Düsseldorf, Germany

19-11-2010

GATC Biotech’s new sequencing laboratory will be their second in Germany and will be located in the Life Science Center Düsseldorf. Through the new facilities, scientists from Northern Germany and adjacent countries will benefit from GATC Biotech’s special overnight service, called ...

more

Former Brahms sales manager boosts LifeCodexx team

03-11-2010

LifeCodexx AG announced that Dr. Martin Burow, a proven expert in the field of prenatal diagnostics, has joined its team as Head of Commercial Operations. Until the middle of 2010 Dr. Burow was Sales Manager Asia – Pacific at Brahms AG, which was taken over by ThermoFisher Scientific in 2009. ...

more

19-05-2010

GATC Biotech is going to sequence samples from brain tumors in children for the world’s largest cancer research project. The aim of the German PedBrainTumor Consortium within the ICGC is to develop innovative diagnostic methods and treatments in order to be able to provide children with ...

more

Former General Manager of Cogenics appointed as CEO

30-04-2010

LifeCodexx AG has started operational research and development work on clinically validated diagnostic tests by using Next Generation Sequencing technologies. The work currently focuses on the field of prenatal diagnostics. LifeCodexx will utilize GATC Biotech’s 20 years of experience as well ...

more